Correlation Between GM and Aeglea Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and Aeglea Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Aeglea Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Aeglea Bio Therapeutics, you can compare the effects of market volatilities on GM and Aeglea Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Aeglea Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Aeglea Bio.

Diversification Opportunities for GM and Aeglea Bio

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between GM and Aeglea is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Aeglea Bio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aeglea Bio Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Aeglea Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aeglea Bio Therapeutics has no effect on the direction of GM i.e., GM and Aeglea Bio go up and down completely randomly.

Pair Corralation between GM and Aeglea Bio

Allowing for the 90-day total investment horizon General Motors is expected to generate 2.11 times more return on investment than Aeglea Bio. However, GM is 2.11 times more volatile than Aeglea Bio Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Aeglea Bio Therapeutics is currently generating about -0.58 per unit of risk. If you would invest  3,864  in General Motors on September 12, 2024 and sell it today you would earn a total of  1,410  from holding General Motors or generate 36.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.85%
ValuesDaily Returns

General Motors  vs.  Aeglea Bio Therapeutics

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in General Motors are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, GM displayed solid returns over the last few months and may actually be approaching a breakup point.
Aeglea Bio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aeglea Bio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Aeglea Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

GM and Aeglea Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and Aeglea Bio

The main advantage of trading using opposite GM and Aeglea Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Aeglea Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aeglea Bio will offset losses from the drop in Aeglea Bio's long position.
The idea behind General Motors and Aeglea Bio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges